A technology designed to restore vision in patients suffering from age-related blindness will be demonstrated by a scientist at NASA Ames Research Center in California’s Silicon Valley today. Developed by NASA Ames in conjunction with the Stanford University School of Medicine, the “Vision Chip” may help improve age-related macular degeneration, the number one cause of blindness in the elderly. “Nanotechnology that could restore vision is an exciting example of how NASA science and engineering, origially intended for outer space, can return enormous dividends for everyday life here on Earth,” said Dr. David J. Loftus, a member of both the Life Sciences Division and the Integrated Product Team on Devices and Nanotechnology at NASA Ames.
From NASA:
NASA TO SHOWCASE INNOVATIVE RESEARCH FOR TREATING BLINDNESS
A technology designed to restore vision in patients suffering from age-related blindness will be demonstrated by a scientist at NASA Ames Research Center in California’s Silicon Valley on Friday, Dec. 6. Organized by the Girvan Institute of Technology, a non-profit public benefit corporation located at the NASA Research Park (NRP), the demo will be held from 9:30 a.m. to 12:00 p.m. PST in Bldg. 3.
Developed by NASA Ames in conjunction with the Stanford University School of Medicine, the “Vision Chip” may help improve age-related macular degeneration, the number one cause of blindness in the elderly.
“Nanotechnology that could restore vision is an exciting example of how NASA science and engineering, origially intended for outer space, can return enormous dividends for everyday life here on Earth,” said Dr. David J. Loftus, a member of both the Life Sciences Division and the Integrated Product Team on Devices and Nanotechnology at NASA Ames.
This device consists of an array of electrically conductive carbon nanotube (CNT) towers grown directly on the surface of a silicon chip. The CNT towers allow signals captured from a charge-coupled device (CCD) to be transmitted directly to the neural elements of the retina, potentially restoring vision.
ScienceBlog.com has no paywalls, no sponsored content, and no agenda beyond getting the science right. Every story here is written to inform, not to impress an advertiser or push a point of view.
Good science journalism takes time — reading the papers, checking the claims, finding researchers who can put findings in context. We do that work because we think it matters.
If you find this site useful, consider supporting it with a donation. Even a few dollars a month helps keep the coverage independent and free for everyone.